(Q44234273)

English

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

scientific article published in December 2002

Statements

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial (English)
Susan L Greenspan
Michael A Bolognese
Anthony L Mulloy
Antonio Lombardi

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit